about
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent...
Read More
155.80
-1.02
(-0.65%)
5.2M
XNYS Volume
XNYS 11 Mar, 2026 5:30 PM (EDT)
High Financial Strength
Mid Valuation
Technically Moderately Bullish
Strong Performer, Getting Expensive
These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying
View Similar
Embed DVM
Novartis AG (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..